Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-10

Clinical Trial Update: A Randomized Double-blind, Placebo Controlled, Multi-center Study to Evaluate the Safety, Tolerability and Potential Effects of the Dietary Supplement Violet™ Molecular Iodine (I2) on Breast Health in Women With Cyclic Breast Discomfort and Tenderness [NA]

View source ↗

Summary

A completed randomized, double-blind, placebo-controlled multi-center trial evaluating the safety, tolerability, and potential effects of Violet Molecular Iodin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Violet Molecular Iodine (I2) (molecular iodine)

Snippet

Sponsor: BioPharmX, Inc. | Conditions: Fibrocystic Breast Condition (FBC) | NA | Status: COMPLETED